DNTH
Dianthus Therapeutics, Inc. /DE/
NASDAQ · Healthcare · Biotechnology · US
$96.81
−4.26%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 3267.41x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.62x
- Price / sales
- 2844.02x
- Price / cash flow
- -34.85x
Enterprise value
- Enterprise value
- $4.5B
- EV / sales
- 2378.93x
- EV / EBITDA
- -153.49x
- EV / EBIT
- -20.79x
- Market cap
- $5.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026